{"organizations": [], "uuid": "ef0af714469a2a400ccd8df9f1160e3e8465be80", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-spago-nanomedical-to-be-granted-us/brief-spago-nanomedical-to-be-granted-us-patent-for-tumorad-idUSFWN1QN0G8", "country": "US", "domain_rank": 408, "title": "BRIEF-Spago Nanomedical To Be Granted US Patent For Tumorad", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.691, "site_type": "news", "published": "2018-03-05T23:01:00.000+02:00", "replies_count": 0, "uuid": "ef0af714469a2a400ccd8df9f1160e3e8465be80"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-spago-nanomedical-to-be-granted-us/brief-spago-nanomedical-to-be-granted-us-patent-for-tumorad-idUSFWN1QN0G8", "ord_in_thread": 0, "title": "BRIEF-Spago Nanomedical To Be Granted US Patent For Tumorad", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}, {"name": "usa", "sentiment": "none"}], "organizations": [{"name": "spago nanomedical", "sentiment": "negative"}, {"name": "reuters", "sentiment": "negative"}, {"name": "spago nanomedical ab", "sentiment": "negative"}, {"name": "eikon", "sentiment": "none"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) - Spago Nanomedical Ab (Publ):\n* SPAGO NANOMEDICAL TO BE GRANTED US PATENT FOR TUMORAD® * ‍PATENT WILL SECURE MARKET EXCLUSIVITY IN USA UNTIL AT LEAST 2035 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-03-05T23:01:00.000+02:00", "crawled": "2018-03-06T22:20:10.021+02:00", "highlightTitle": ""}